Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:1069-1076
Published online before print September 26, 2005, doi: 10.1161/01.HYP.0000186329.92187.2e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/5/1069    most recent
01.HYP.0000186329.92187.2ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danser, A.H. J.
Right arrow Articles by Deinum, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danser, A.H. J.
Right arrow Articles by Deinum, J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Hazardous Substances DB
*RENNIN
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Cardiovascular Pharmacology
Right arrow ACE/Angiotension receptors
Right arrow Hypertension - basic studies
Right arrow Receptor pharmacology
Right arrow Other Vascular biology

(Hypertension. 2005;46:1069.)
© 2005 American Heart Association, Inc.


Brief Reviews

Renin, Prorenin and the Putative (Pro)renin Receptor

A.H. Jan Danser; Jaap Deinum

From the Department of Pharmacology (A.H.J.D.), Erasmus MC, Rotterdam; and the Department of Internal Medicine (J.D.), UMCN St. Radboud, Nijmegen, The Netherlands

Correspondence to A.H.J. Danser, Department of Pharmacology, Room EE1418b, Erasmus MC, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands. E-mail a.danser@erasmusmc.nl


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Renin is an aspartic protease that consists of 2 homologous lobes. The cleft in between contains the active site with 2 catalytic aspartic residues.1 Unlike other aspartic proteases such as pepsin or cathepsin D, renin is monospecific and only cleaves angiotensinogen, to generate angiotensin (Ang) I. Ang I is the precursor of the active end-product of the renin-angiotensin system (RAS), Ang II.

Renin has also been called active renin to underline that an enzymatically inactive form of renin exists. In 1971, Lumbers found that amniotic fluid, left at low pH in the cold, acquired renin activity.2 Later, Skinner described a similar phenomenon in plasma.3 Acidification was not strictly necessary for this increase in Ang I-generating activity, because incubation at low temperature also increased renin activity, albeit to only 15% of activity after acidification. Soon it was postulated that this inactive, but activatable "big" renin (its molecular weight was 5 kDa higher than that of renin) was the biosynthetic precursor of renin. Hence, it was named prorenin. Only with the cloning of the renin gene in 1984 was prorenin definitively proved to be the precursor of renin.4 For reasons that are unknown, prorenin circulates in human plasma in excess to renin, sometimes at concentrations that are 100-times higher.5 Prorenin has also been demonstrated in plasma of cat, dog, cattle, pig, horse, sheep, rabbit, rat, and mouse.

A 43-amino acid N-terminal propeptide explains the absence of enzymatic activity of prorenin. This propeptide covers the enzymatic cleft and obstructs access of angiotensinogen to . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
HypertensionHome page
A.H. J. Danser
Does Prorenin Exert Angiotensin-Independent Effects In Vivo?
Hypertension, December 1, 2009; 54(6): 1218 - 1220.
[Full Text] [PDF]


Home page
Diabetes CareHome page
F. Persson, P. Rossing, H. Reinhard, T. Juhl, C. D.A. Stehouwer, C. Schalkwijk, A.H. J. Danser, F. Boomsma, E. Frandsen, and H.-H. Parving
Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
Diabetes Care, October 1, 2009; 32(10): 1873 - 1879.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A.H. J. Danser
(Pro)renin Receptor and Vacuolar H+-ATPase
Hypertension, August 1, 2009; 54(2): 219 - 221.
[Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
P. S Sever, A. H Gradman, and M. Azizi
Managing cardiovascular and renal risk: the potential of direct renin inhibition
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2009; 10(2): 65 - 76.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
H.-H. Parving, B. M. Brenner, John. J. V. McMurray, D. de Zeeuw, S. M. Haffner, S. D. Solomon, N. Chaturvedi, M. Ghadanfar, N. Weissbach, Z. Xiang, et al.
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1663 - 1671.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. J. Campbell, J. Nussberger, M. Stowasser, A.H. J. Danser, A. Morganti, E. Frandsen, and J. Menard
Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement
Clin. Chem., May 1, 2009; 55(5): 867 - 877.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
J. Peti-Peterdi, I. Toma, A. Sipos, and S. L. Vargas
Multiphoton Imaging of Renal Regulatory Mechanisms
Physiology, April 1, 2009; 24(2): 88 - 96.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Klotz, D. Burkhoff, I. M. Garrelds, F. Boomsma, and A.H.J. Danser
The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
Eur. Heart J., April 1, 2009; 30(7): 805 - 812.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Krop, I. M. Garrelds, R. J.A. de Bruin, J. M.G. van Gool, N. D.L. Fisher, N. K. Hollenberg, and A.H. Jan Danser
Aliskiren Accumulates in Renin Secretory Granules and Binds Plasma Prorenin
Hypertension, December 1, 2008; 52(6): 1076 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Peti-Peterdi, J. J. Kang, and I. Toma
Activation of the renal renin-angiotensin system in diabetes--new concepts
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3047 - 3049.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Zhang, N. A. Noble, W. A. Border, R. T. Owens, and Y. Huang
Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E810 - E819.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
W. W Batenburg and A. J. Danser
Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskiren
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 181 - 184.
[PDF]


Home page
HypertensionHome page
J. Nussberger, A. Stanton, N. D.L. Fisher, N. K. Hollenberg, and A.H. Jan Danser
Response to It Is the Plasma Renin Activity Level That Counts, not Stoichiometry
Hypertension, August 1, 2008; 52(2): e21 - e21.
[Full Text] [PDF]


Home page
CirculationHome page
N. D.L. Fisher, A.H. Jan Danser, J. Nussberger, W. P. Dole, and N. K. Hollenberg
Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans
Circulation, June 24, 2008; 117(25): 3199 - 3205.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. J. Kang, I. Toma, A. Sipos, E. J. Meer, S. L. Vargas, and J. Peti-Peterdi
The Collecting Duct Is the Major Source of Prorenin in Diabetes
Hypertension, June 1, 2008; 51(6): 1597 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
H. M. Siragy and J. Huang
Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity
Exp Physiol, May 1, 2008; 93(5): 709 - 714.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
G. Nguyen and A. H. J. Danser
Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents
Exp Physiol, May 1, 2008; 93(5): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Campbell
Critical Review of Prorenin and (Pro)renin Receptor Research
Hypertension, May 1, 2008; 51(5): 1259 - 1264.
[Full Text] [PDF]


Home page
HypertensionHome page
A. H. J. Danser, A. Charney, D. L. Feldman, J. Nussberger, N. Fisher, and N. Hollenberg
The Renin Rise With Aliskiren: It's Simply Stoichiometry
Hypertension, April 1, 2008; 51(4): e27 - e28.
[Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. J. Danser
The rise in renin following renin inhibition: an assay-artefact?
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2008; 9(1_suppl): S12 - S12.
[PDF]


Home page
J Am Coll CardiolHome page
A. H. Gradman and R. Kad
Renin inhibition in hypertension.
J. Am. Coll. Cardiol., February 5, 2008; 51(5): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Campbell
Interpretation of Plasma Renin Concentration in Patients Receiving Aliskiren Therapy
Hypertension, January 1, 2008; 51(1): 15 - 18.
[Full Text] [PDF]


Home page
PhysiologyHome page
F. Schweda, U. Friis, C. Wagner, O. Skott, and A. Kurtz
Renin Release
Physiology, October 1, 2007; 22(5): 310 - 319.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M. J Brown
Renin: friend or foe?
Heart, September 1, 2007; 93(9): 1026 - 1033.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. C. Luft
Renin and Its Putative Receptor Remain Enigmas
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 1989 - 1992.
[Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
F. Suzuki
Nonproteolytic activation of prorenin by the (pro)renin receptor is blocked by decoy peptide
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2007; 8(2): 101 - 103.
[PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
J. L Zhuo and X. C Li
Review: Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2007; 8(1): 23 - 33.
[Abstract] [PDF]


Home page
Circ. Res.Home page
W. C. De Mello
On the Pathophysiological Implications of an Intracellular Renin Receptor
Circ. Res., December 8, 2006; 99(12): 1285 - 1286.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. H. Schefe, M. Menk, J. Reinemund, K. Effertz, R. M. Hobbs, P. P. Pandolfi, P. Ruiz, T. Unger, and H. Funke-Kaiser
A Novel Signal Transduction Cascade Involving Direct Physical Interaction of the Renin/Prorenin Receptor With the Transcription Factor Promyelocytic Zinc Finger Protein
Circ. Res., December 8, 2006; 99(12): 1355 - 1366.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Krop, J. H.M. van Esch, and A.H. J. Danser
Letter by Krop et al Regarding Article, "Role of p90 Ribosomal S6 Kinase-Mediated Prorenin-Converting Enzyme in Ischemic and Diabetic Myocardium"
Circulation, October 24, 2006; 114(17): e556 - e556.
[Full Text] [PDF]


Home page
HypertensionHome page
J. J. Saris, P. A.C. 't Hoen, I. M. Garrelds, D. H.W. Dekkers, J. T. den Dunnen, J. M.J. Lamers, and A.H. Jan Danser
Prorenin Induces Intracellular Signaling in Cardiomyocytes Independently of Angiotensin II
Hypertension, October 1, 2006; 48(4): 564 - 571.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
D. N. Muller and F. C. Luft
Direct Renin Inhibition with Aliskiren in Hypertension and Target Organ Damage
Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 221 - 228.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. J. Danser and J. Deinum
Spotlight on Renin: Renin, Prorenin and the Putative (Pro)renin Receptor
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 163 - 165.
[PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
G. Nguyen
The (pro)renin receptor: biochemistry and potential significance
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 166 - 166.
[PDF]